According to Pfizer and BioNTech, their vaccine also works when infected with the British or South African variant of the corona virus
"Small differences" found during research are unlikely to make the corona vaccine much less effective, the companies said in a statement Thursday. The companies emphasize that they continue to monitor how effective the corona vaccine is in practice. They promise to take action when needed. (28-1-2021)
Scientists at Oxford University are hard at work developing new versions of the AstraZeneca vaccine that are effective against the corona variants from South Africa, Brazil and the United Kingdom, the British newspaper Daily Telegraph reports. (21-1-2021)
AstraZeneca will deliver fewer vaccines than expected in the first quarter. This is because a European production has been send to UK. The European Commission informed AstraZeneca on Monday 25-1 that it expects the contractually agreed amount of doses to be expected as soon as possible. Governments want to know what they can count on. This is necessary in order, for example, to be able to decide whether they should keep doses on hand to be able to administer the necessary second injection to vaccinated people. (27-1-2021)
Amsterdam UMC started a major investigation into a new corona vaccine. Hospitals around the world are participating in the study, which requires a total of 36 thousand participants. The vaccine, CureVac, has already been purchased by the Dutch government and is now in the final testing phase. Amsterdammers who want to participate can register via this website.
Back to top